Overview

A Study of Duloxetine in the Treatment of Fibromyalgia

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate duloxetine for the treatment of fibromyalgia syndrome patients.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride